Home - Panaxium
Panaxium’s precision therapy BMI platform is built for surgeons and neurologists to directly intervene, treat the injury, and leave the patient to return to a life of normalcy.
About - Panaxium
Dr. Huberfeld collaborates and advises Panaxium regarding device-tissue electrophysiology, and in the development of Panaxium’s technology for intraoperative monitoring using high …
The Science - Panaxium
Panaxium’s proprietary MRI protocol & AI-assisted analysis generates complete patient-specific representations of entire functional networks. Identifies specific disruption from damage, …
Synaptive Medical Partners with Panaxium to Bring Real-Time …
Oct 11, 2022 · Novel platform integrates Panaxium micro-precision cortical electrodes array into Synaptive Modus V robotic exoscope technology to provide clinicians with unprecedented real …
Dr. Gilles Huberfeld to Lead First In-Human Trial of ... - Panaxium
Nov 1, 2022 · Panaxium announces that Dr. Gilles Huberfeld, MD, PhD, neurologist and researcher at Hôpital Fondation Adolphe de Rothschild, is leading the 1st humans patient …
Panaxium Named to Canada’s Top 20 Moonshot Ventures of 2025
May 20, 2025 · Panaxium’s approach combines advanced neurostimulation with precision imaging to enable recovery of motor function, representing a significant shift in how brain injury …
Careers - Panaxium
We believe in achieving the extraordinary.
Dr. George Malliaras and Dr. Róisín Owens Join ... - Panaxium
May 7, 2025 · ABOUT PANAXIUM Founded in 2016, Panaxium is a new and rapidly-growing bioelectronic medicine company aiming to fundamentally change the way disease is treated.
Bioelectronic Medicine Company Panaxium SAS To Open R&D …
May 7, 2025 · Bioelectronic medicine company Panaxium SAS today announced that it has selected a location for its new permanent R&D Centre in Aix-en-Provence, France. The Centre …
Contact - Panaxium
Send us a message An international team with locations in France and Canada Aix-en-Provence © 2025 Panaxium. All rights reserved.